TY - JOUR
T1 - In vitro susceptibility of gram-negative bacilli from pediatric patients to moxalactam, cefotaxime, Ro 13-9904, and other cephalosporins
AU - Shelton, S.
AU - Nelson, J. D.
AU - McCracken, G. H.
PY - 1980
Y1 - 1980
N2 - Moxalactam, Ro 13-9904, cefotaxime, cefoperazone, older cephalosporins, and four aminoglycosides were tested in vitro against 432 strains of gram-negative bacteria isolated from pediatric patients. The new drugs were uniformly active against coliform bacilli obtained from patients with meningitis and against aminoglycoside-resistant coliform bacilli.
AB - Moxalactam, Ro 13-9904, cefotaxime, cefoperazone, older cephalosporins, and four aminoglycosides were tested in vitro against 432 strains of gram-negative bacteria isolated from pediatric patients. The new drugs were uniformly active against coliform bacilli obtained from patients with meningitis and against aminoglycoside-resistant coliform bacilli.
UR - http://www.scopus.com/inward/record.url?scp=0019212448&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0019212448&partnerID=8YFLogxK
U2 - 10.1128/AAC.18.3.476
DO - 10.1128/AAC.18.3.476
M3 - Article
C2 - 6252837
AN - SCOPUS:0019212448
SN - 0066-4804
VL - 18
SP - 476
EP - 479
JO - Antimicrobial agents and chemotherapy
JF - Antimicrobial agents and chemotherapy
IS - 3
ER -